Is exocrine pancreatic insufficiency in adult coeliac disease a cause of persisting symptoms?

Alimentary Pharmacology and Therapeutics

Volumn 25, Issue 3, 2007, Pages 265-271

  Leeds, J S ^a,b   Hopper, A D ^a   Hurlstone, D P ^a   Edwards, S J ^a   Mcalindon, M E ^a   Lobo, A J ^a   Donnelly, M T ^a   Morley, S ^b   Sanders, D S ^a  

^a SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^b ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTASE; FAECAL ELASTASE 1; PANCREAS ENZYME; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BODY WEIGHT; CELIAC DISEASE; CHRONIC DIARRHEA; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DRUG DOSE TITRATION; ENZYME THERAPY; FECES ANALYSIS; FECES INCONTINENCE; FEMALE; GLUTEN FREE DIET; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS EXOCRINE INSUFFICIENCY; PREVALENCE; PRIORITY JOURNAL; SYMPTOM; TREATMENT OUTCOME;

ADULT; CELIAC DISEASE; DIARRHEA; EXOCRINE PANCREATIC INSUFFICIENCY; FEMALE; GLUTEN; HUMANS; MALE; MIDDLE AGED; PANCREATIC FUNCTION TESTS;

EID: 33846288269     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03206.x     Document Type: Article

References (42)

1. West J, Logan RF, Hill PG, et al. Seroprevalence, correlates, and characteristics of undetected coeliac disease in England. Gut 2003; 52: 960-5.
2. Fasano A, Berti I, Geraduzzi T, et al. Prevalence of coeliac disease in at-risk and not-at-risk groups in the United States. AMA Arch Intern Med 2003; 163: 286-92.
3. Green PH, Jabri B. Coeliac disease. Lancet 2003; 362: 383-91.
4. Green PH. The many faces of coeliac disease: clinical presentation of coeliac disease in the adult population. Gastroenterology 2005; 128 (4 Suppl. 1): S74-8.
5. Sanders DS, Hurlstone DP, Stokes RO, et al. The changing face of coeliac disease: experience of a single University Hospital in South Yorkshire. Postgrad Med J 2002; 78: 31-3.
6. Fine KD, Meyer RL, Lee EL. The prevalence and causes of chronic diarrhoea in patients with coeliac sprue treated with a gluten free diet. Gastroenterology 1997; 112: 1830-8.
7. O'Mahony S, Howdle PD, Losowsky MS. Review article: Management of patients with non-responsive coeliac disease. Aliment Pharmacol Ther 1996; 10: 671-80.
8. Abdulkarim AS, Burgart LJ, See J, Murray JA. Etiology of nonresponsive coeliac disease: results of a systematic approach. Am J Gastroenterol 2002; 97: 2016-21.
9. Dreiling DA. The pancreatic secretion in the malabsorption syndrome and related malnutrition states. J Mt Sinai Hosp N Y 1957; 24: 243-50.
10. Di Magno EP, Go VLW, Summerskill WHJ. Impaired cholecystokinin- pancreozymin secretion, intraluminal dilution, and maldigestion of fat in sprue. Gastroenterology 1972; 63: 25-32.
11. Regan PT, DiMagno EP. Exocrine pancreatic insufficiency in coeliac sprue: a cause of treatment failure. Gastroenterology 1980; 78: 484-7.
12. Weizman Z, Hamilton JR, Kopelman HR, Cleghorn G, Durie PR. Treatment failure in coeliac disease due to coexistent exocrine pancreatic insufficiency. Pediatrics 1987; 80: 924-6.
13. Freeman HJ. Hepatobiliary tract and pancreatic disorders in coeliac disease. Can J Gastroenterol 1997; 11: 77-81.
14. Lankisch PG. Now that faecal elastase is available in the United States, should clinicians start using it? Curr Gastroenterol Rep 2004; 6: 126-31.
15. Dominguez-Munoz JE, Hieronymus C, Sauerbruch T, Malfertheiner P. Faecal elastase test: evaluation of a new noninvasive pancreatic function test. Am J Gastroenterol 1995; 90: 1834-7.
16. Stein J, Jung M, Sziegoleit A, Zeuzem S, Caspary WF, Lembcke B. Immunoreactive elastase 1: clinical evaluation of a new non-invasive test of pancreatic function. Clin Chem 1996; 42: 222-6.
17. Löser C, Moullgaard A, Folsch UR. Faecal elastase 1: a novel, highly sensitive, and tubeless pancreatic function test. Gut 1996; 39: 580-6.
18. Glasbrenner B, Schön A, Klatt S, Beckh K, Adler G. Clinical evaluation of the faecal elastase test in the diagnosis and staging of chronic pancreatitis. Eur J Gastroenterol Hepatol 1996; 8: 1117-20.
19. Katschinski M, Schirra J, Bross A, Goke B, Arnold R. Duodenal secretion and faecal excretion of pancreatic elastase-1 in healthy humans and patients with chronic pancreatitis. Pancreas 1997; 15: 191-200.
20. Lankisch PG, Schmidt I, Konig H, et al. Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 1998; 42: 551-4.
21. Carroccio A, Verghi F, Santini B, et al. Diagnostic accuracy of faecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption. A collaborative study of the Italian society of pediatric gastroenterology and hepatology. Dig Dis Sci 2001; 46: 1335-42.
22. Walkowiak J, Herzig KH, Strzykala K, Przyslawski J, Krawczynski M. Faecal elastase-1 is superior to faecal chymotrypsin in the assessment of pancreatic involvement in cystic fibrosis. Pediatrics 2002; 110: e7.
23. Sonwalkar SA, Holbrook IB, Phillips I, Kelly SM. A prospective, comparative study of the para-aminobenzoic acid test and faecal elastase 1 in the assessment of exocrine pancreatic function. Aliment Pharmacol Ther 2003; 17: 467-71.
24. Elphick DA, Kapur K. Comparing the urinary pancreolauryl ratio and faecal elastase-1 as indicators of pancreatic insufficiency in clinical practice. Pancreatology 2005; 5: 196-200.
25. Carroccio A, Iacono G, Lerro P, et al. Role of pancreatic impairment in growth recovery during gluten-free diet in childhood celiac disease. Gastroenterology 1997; 112: 1839-44.
26. Carroccio A, Iacono G, Ippolito S, et al. Usefulness of faecal elastase-1 assay in monitoring pancreatic function in childhood coeliac disease. Ital J Gastroenterol Hepatol 1998; 30: 500-4.
27. Nousia-Arvanitakis S, Karagiozogiou-Lamboudes T, Aggouridaki C, Malaka-Lambrellis E, Galli-Tsinopoulou A, Xefteri M. Influence of jejunal morphology changes on exocrine pancreatic function in coeliac disease. J Pediatr Gastroenterol Nutr 1999; 29: 81-5.
28. Walkowiak J, Herzig KH. Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease. Eur J Clin Invest 2001; 31: 425-30.
29. Gomez JC, Moran CE, Maurino EC, Bai JC. Exocrine pancreatic insufficiency in coeliac disease. Gastroenterology 1998; 114: 621-3.
30. Marsh MN. The natural history of gluten sensitivity: defining, refining and re-defining. Q J Med 1995; 85: 9-13.
31. Pietzak MM. Follow-up of patients with coeliac disease: achieving compliance with treatment. Gastroenterology 2005; 128: S135-141.
32. Thomas PD, Forbes A, Green J, et al. Guidelines for the investigation of chronic diarrhoea. Gut 2003; 52 (Suppl. V): v1-v15.
33. Deprez P, Sempoux C, Van Beers BE, et al. Persistent decreased plasma cholecystokinin levels in coeliac patients under gluten free diet: respective roles of histological changes and nutrient hydrolysis. Regul Pept 2002; 55: 79-84.
34. Wahab PJ, Hopman WP, Jansen JB. Basal and fat-stimulated plasma peptide YY levels in coeliac disease. Dig Dis Sci 2001; 46: 2504-9.
35. Carroccio A, Iacono G, Montalto G, et al. Pancreatic insufficiency in coeliac disease is not dependent on nutritional status. Dig Dis Sci 1994; 39: 2235-42.
36. Brydon WG, Kingstone K, Ghosh S. Limitations of faecal elastase-1 and chymotrypsin as tests of exocrine pancreatic disease in adults. Ann Clin Biochem 2004; 41: 78-81.
37. Fischer B, Hoh S, Wehler M, Hahn EG, Schneider HT. Faecal elastase-1: lyophilization of stool samples prevents false low results in diarrhoea. Scand J Gastroenterol 2001; 36: 771-4.
38. Walkowiak J. Faecal elastase-1: clinical value in the assessment of exocrine pancreatic function in children. Eur J Pediatr 2000; 159: 869-70.
39. Carroccio A, Fontana M, Spagnuolo MI, et al. Pancreatic dysfunction and its association with fat malabsorption in HIV infected children. Gut 1998; 43: 558-63.
40. Carroccio A, Guarino A, Zuin G, et al. Efficacy of oral pancreatic enzyme therapy for the treatment of fat malabsorption in HIV-infected patients. Aliment Pharmacol Ther 2001; 15: 1619-25.
41. Carroccio A, Iacono G, Montalto G, et al. Pancreatic enzyme therapy in childhood coeliac disease. A double-blind prospective randomized study. Dig Dis Sci 1995; 40: 2555-60.
42. Dickey W, Bodkin S. Prospective study of body mass index in patients with coeliac disease. Br Med J 1998; 317: 1290.